Leo Middelberg
Zinzino klient
Tere tulemast! Mul on tellitud toodetega olnud suurepäraseid kogemusi ja arvan, et need meeldivad ka teile. Andke mulle teada, mida neist arvate!
Investor relations
Financial calendar
Zinzino Bokslutskommuniké 2024
Zinzino Year-End Report 2024
Annualreport 2024
Årsredovisning 2024
Financial reports
Press releases
ZINZINO AB (PUBL.): ENTERS INTO AGREEMENT TO PROVIDE DIP FINANCING TO ZURVITA INITIATING CHAPTER 11 PROCESS
laupäev, 21. detsember 2024 20:00
AvaZINZINO AB (PUBL): Zinzino announces Canary Islands as next step in its global expansion
kolmapäev, 13. november 2024 15:00
AvaZINZINO AB (PUBL): Share subscription due to directed set-off issues
neljapäev, 19. september 2024 15:30
AvaZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
neljapäev, 27. juuni 2024 11:00
AvaZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA
esmaspäev, 17. juuni 2024 11:00
AvaZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion
teisipäev, 11. juuni 2024 15:30
AvaZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power
reede, 7. juuni 2024 12:00
AvaZINZINO AB (PUBL): Zinzino acquires assets in Xelliss – strategic reinforcement in southern Europe and in the microalgae spirulina
pühapäev, 12. mai 2024 13:00
AvaZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
reede, 26. aprill 2024 8:00
AvaZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million.
esmaspäev, 29. jaanuar 2024 10:00
AvaZINZINO AB (PUBL): Zinzino changes Certified Adviser to Carnegie Investment Bank AB (publ)
neljapäev, 30. november 2023 9:00
AvaZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion
reede, 22. september 2023 8:00
AvaZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023
teisipäev, 2. mai 2023 8:00
AvaZINZINO AB (PUBL): Zinzino launches Turkey as a next market on their road towards global expansion
teisipäev, 7. märts 2023 14:30
AvaGrowing interest in personal health and customized supplements can be a great investment case
esmaspäev, 28. november 2022 14:30
AvaZINZINO AB (PUBL): Share subscription due to directed offset issue
kolmapäev, 26. oktoober 2022 16:30
AvaZinzino announces the launch of Singapore as next step in their global expansion
neljapäev, 7. aprill 2022 11:30
AvaZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
kolmapäev, 6. aprill 2022 9:30
AvaZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
neljapäev, 18. november 2021 14:00
AvaZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
teisipäev, 9. november 2021 11:30
AvaZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
neljapäev, 9. september 2021 13:00
AvaZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
neljapäev, 3. juuni 2021 11:00
AvaZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
neljapäev, 15. aprill 2021 15:00
AvaZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
teisipäev, 6. aprill 2021 14:00
AvaZINZINO AB (PUBL): Further expansions of the Zinzino global web shop
teisipäev, 15. detsember 2020 16:15
AvaZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
kolmapäev, 16. september 2020 10:00
AvaZINZINO AB (PUBL): ONE-TIME EFFECT DUE TO CHANGED ACCOUNTING FOR DISTRIBUTOR REMUNERATION IMPROVES Q1 2020 WITH SEK 22.2 MILLION BEFORE TAX
teisipäev, 5. mai 2020 12:00
AvaZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets
reede, 25. oktoober 2019 16:40
AvaZINZINO AB (PUBL): THE BOARD DECIDES TO ISSUE 200 000 STOCK OPTIONS
esmaspäev, 15. oktoober 2018 15:00
AvaZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2018
neljapäev, 11. oktoober 2018 13:00
AvaZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN
reede, 1. juuni 2018 11:00
AvaZINZINO AB (PUBL): Q1; CONTINUED SOUND GROWTH AND STRONG PROFITABILITY IMPROVEMENT, EBITDA RISING BY 45%
teisipäev, 15. mai 2018 8:00
AvaZINZINO LAUNCHES NEW PRODUCT: ENERGY BAR - DELICIOUS AND HEALTHY!
esmaspäev, 12. märts 2018 17:00
AvaZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS
kolmapäev, 28. veebruar 2018 8:00
AvaZINZINO AB (PUBL): PRELIMINARY SALES REPORT FOR Q4 AND 2017 WITH PROPOSAL TO INCREASE DIVIDEND
reede, 19. jaanuar 2018 18:00
AvaInterim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.
esmaspäev, 13. november 2017 8:30
AvaZinzino launches groundbreaking product: BalanceOil Vegan for the heart and brain
reede, 20. oktoober 2017 13:00
AvaZINZINO AB (PUBL): CORRECTION: PRELIMINARY SALES REPORT THIRD QUARTER 2017
teisipäev, 10. oktoober 2017 17:00
AvaZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2017
esmaspäev, 9. oktoober 2017 11:00
AvaInterim Report, Zinzino, April – June 2017: Very strong growth of 28% and full-scale launch of a new digital platform
neljapäev, 31. august 2017 9:00
AvaZINZINO LAUNCHES VIVA, A NEW DIETARY SUPPLEMENT PROMOTING BETTER SLEEP, REDUCING STRESS AND INCREASING WELL-BEING
reede, 30. juuni 2017 15:00
AvaZinzino AB (publ.) appointed “Growth Company of the Year 2016” in direct sales
reede, 2. juuni 2017 16:00
AvaZinzino begins selling in Switzerland ”Rich in capital and an important market”
teisipäev, 16. mai 2017 16:00
AvaInterim Report, January – March 2017: Zinzino continues to deliver strong growth and is well prepared for increased profitability
kolmapäev, 10. mai 2017 9:00
AvaZinzino taking the Omega-6/Omega-3 concept to new heights with water-miscible AquaX oil
neljapäev, 7. juuli 2016 16:24
AvaZinzino expands sales to all EU countries “We see a huge potential”
teisipäev, 5. juuli 2016 11:10
AvaYear-End Report 1st January - 31st December 2015, Zinzino AB (publ)
esmaspäev, 29. veebruar 2016 11:53
AvaSweden's Zinzino is improving its foothold in Europe – with the establishment of operations in Germany
esmaspäev, 22. veebruar 2016 8:00
AvaZinzino launches Zinzino LeanShake – a nutritious meal replacement for weight control
reede, 11. detsember 2015 11:58
AvaSwedish Zinzino continues to grow internationally with its establishment in Canada
neljapäev, 17. september 2015 9:28
AvaZinzino AB (publ) acquires further 13.8 per cent of Faun Pharma AS – safeguarding continued research and expanded product range
reede, 6. märts 2015 10:29
AvaFinancial Statements 1 January - 31 December 2014, Zinzino AB (publ)
reede, 27. veebruar 2015 14:39
AvaThe stock
Sustainability Report
Read more about our sustainability approach, targets and 2023 performance.
Greta Billing
shares@zinzino.com
+46 73 627 17 54
Fredrik Nielsen
shares@zinzino.com
+46 (0)707 900 174
Certified Adviser
All companies whose shares are to be traded on the Nasdaq First North Premier Growth Market have a certified adviser who guides and supports the company through the listing process. Subsequently, the adviser monitors that the company complies with First North's regulations for providing information to the market and investors. Carnegie Investment Bank AB (publ) is the Certified Adviser for Zinzino AB.
Certified Adviser:
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
Jagage seda lehte
Või kopeerige link